相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preprotein signature for full susceptibility to the co-translational translocation inhibitor cyclotriazadisulfonamide
Victor Van Puyenbroeck et al.
TRAFFIC (2020)
A Fas-4-1BB fusion protein converts a death to a pro-survival signal and enhances T cell therapy
Shannon K. Oda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency
Mohammed F. Alosaimi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
A Proteomic Survey Indicates Sortilin as a Secondary Substrate of the ER Translocation Inhibitor Cyclotriazadisulfonamide (CADA)
Victor Van Puyenbroeck et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
4-1BB agonism: adding the accelerator to cancer immunotherapy
Cariad Chester et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Time-Dependent Regulation of IL-2R α-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes
Alla N. Shatrova et al.
PLOS ONE (2016)
Ribonuclease-neutralized pancreatic microsomal membranes from livestock for in vitro co-translational protein translocation
Kurt Vermeire et al.
ANALYTICAL BIOCHEMISTRY (2015)
4-1 BB agonists: multi-potent potentiators of tumor immunity
Todd Bartkowiak et al.
FRONTIERS IN ONCOLOGY (2015)
CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation
Emmanuel Martin et al.
NATURE (2014)
Signal Peptide-Binding Drug as a Selective Inhibitor of Co-Translational Protein Translocation
Kurt Vermeire et al.
PLOS BIOLOGY (2014)
CD4 blockade directly inhibits mouse and human CD4+ T cell functions independent of Foxp3+ Tregs
C. T. Mayer et al.
JOURNAL OF AUTOIMMUNITY (2013)
Spleen-Resident CD4+ and CD4- CD8α- Dendritic Cell Subsets Differ in Their Ability to Prime Invariant Natural Killer T Lymphocytes
Emilie Bialecki et al.
PLOS ONE (2011)
Fc-dependent expression of CD137 on human NK cells: insights into agonistic effects of anti-CD137 monoclonal antibodies
Wei Lin et al.
BLOOD (2008)
The concept of translocational regulation
Ramanujan S. Hegde et al.
JOURNAL OF CELL BIOLOGY (2008)
Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes
Tom A. Rapoport
NATURE (2007)
Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation
Zhengguo Xiao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor downmodulating activity
Kurt Vermeire et al.
BIOCHEMICAL PHARMACOLOGY (2007)
CD4 expression on activated NK cells: Ligation of CD4 induces cytokine expression and cell migration
Helene B. Bernstein et al.
JOURNAL OF IMMUNOLOGY (2006)
Synthesis and structure-activity relationship studies of CD4 down-modulating cyclotriazadisulfonamide (CADA) analogues
TW Bell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Protein translocation across biological membranes
W Wickner et al.
SCIENCE (2005)
Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity
M Krogsgaard et al.
NATURE (2005)
Induction of immunological tolerance/hyporesponsiveness in baboons with a nondepleting CD4 antibody
D Winsor-Hines et al.
JOURNAL OF IMMUNOLOGY (2004)
Role of 4-1BB in allograft rejection mediated by CD8+ T cells
J Wang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
The anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor
K Vermeire et al.
MOLECULAR PHARMACOLOGY (2003)
Antibody-mediated stripping of CD4 from lymphocyte cell surface in patients with rheumatoid arthritis
TW Hepburn et al.
RHEUMATOLOGY (2003)
CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor
K Vermeire et al.
VIROLOGY (2002)
Immune responses in 4-1BB (CD137)-deficient mice
BS Kwon et al.
JOURNAL OF IMMUNOLOGY (2002)
OX40: targeted immunotherapy - implications for tempering autoimmunity and enhancing vaccines
AD Weinberg
TRENDS IN IMMUNOLOGY (2002)
4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy
JL Cannons et al.
JOURNAL OF IMMUNOLOGY (2001)
Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4
MP Reddy et al.
JOURNAL OF IMMUNOLOGY (2000)
4-1BB: Still in the midst of Darkness
B Kwon et al.
MOLECULES AND CELLS (2000)
分享论文
